We are live on ! Find out more
SRGA

Surgalign Holdings, Inc. Common Stock
SRGA

Delisted

SRGA was delisted on the 30th of June, 2023.

Back to rankings

25 hedge funds and large institutions have $109K invested in Surgalign Holdings, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 6

31% less funds holding

Funds holding: 36 → 25 (-11)

73% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 15

97% less capital invested

Capital invested by funds: $3.89M → $109K (-$3.78M)

Holders
25
Holders Change
-11
Holders Change %
-30.56%
% of All Funds
0.39%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
5
Reduced
6
Closed
15
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
HF
HRT Financial
New York
+$92.6K
2
RJFSA
Raymond James Financial Services Advisors
Florida
+$76.7K
3
CSS
Cubist Systematic Strategies
Connecticut
+$46.7K
4
UBS Group
UBS Group
Switzerland
+$46.1K
5
TSS
Two Sigma Securities
New York
+$26.7K

Top Sellers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
-$2.09M
2
AWS
Atria Wealth Solutions
New York
-$575K
3
Vanguard Group
Vanguard Group
Pennsylvania
-$284K
4
HighTower Advisors
HighTower Advisors
Illinois
-$93K
5
Renaissance Technologies
Renaissance Technologies
New York
-$85K
Name Holding Trade Value Shares
Change 		Change in
Stake
AC
26
Armistice Capital
New York
– -$2.09M -1,309,000 Closed
AWS
27
Atria Wealth Solutions
New York
– -$575K -359,575 Closed
Vanguard Group
28
Vanguard Group
Pennsylvania
– -$284K -177,793 Closed
HighTower Advisors
29
HighTower Advisors
Illinois
– -$93K -58,232 Closed
Renaissance Technologies
30
Renaissance Technologies
New York
– -$85K -53,414 Closed
Geode Capital Management
31
Geode Capital Management
Massachusetts
– -$71.5K -44,698 Closed
BlackRock
32
BlackRock
New York
– -$66.4K -41,513 Closed
BCM
33
Bridgeway Capital Management
Texas
– -$40K -25,000 Closed
DP
34
Dearborn Partners
Illinois
– -$26.7K -16,666 Closed
State Street
35
State Street
Massachusetts
– -$25.3K -15,829 Closed
Northern Trust
36
Northern Trust
Illinois
– -$19.2K -11,984 Closed
TRCT
37
Tower Research Capital (TRC)
New York
– -$10K -6,421 Closed
GTAM
38
Global Trust Asset Management
Florida
– -$5.33K -3,333 Closed
OCM
39
Orion Capital Management
California
– -$638 -399 Closed
AWM
40
Accel Wealth Management
Iowa
– -$371 -232 Closed
1
2

SRGA Hedge Fund Activity: Q2 2023 in Review

25 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Surgalign Holdings, Inc. Common Stock (SRGA) for Q2 2023, worth a combined $109K — down 97% from $3.89M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of SRGA and 4 opened new positions — a net loss of 11 holders — while 6 trimmed existing stakes and 5 added.

The largest buyer was HRT Financial, opening a new position worth an estimated $92.6K. The largest seller was Armistice Capital, exiting entirely with an estimated $2.09M sold.

  • 25 institutional investors held Surgalign Holdings, Inc. Common Stock (SRGA) as of Q2 2023, down from 36 in Q1 2023.
  • Funds reported $109K of Surgalign Holdings, Inc. Common Stock stock for Q2 2023, down 97% quarter-over-quarter.
  • 4 funds opened new Surgalign Holdings, Inc. Common Stock positions in Q2 2023 and 15 closed out, a net change of -11 holders.
  • The largest Surgalign Holdings, Inc. Common Stock buyer in Q2 2023 was HRT Financial, an estimated $92.6K added.
  • The largest Surgalign Holdings, Inc. Common Stock seller in Q2 2023 was Armistice Capital, an estimated $2.09M sold.

Based on aggregated 13F filings for Q2 2023.